Wissenschaftliche Arbeiten

Uzm. Dr. Beliz Bahar Karaoğlan

39 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.

Zurück zum Profil

  1. Survival Outcomes in ERBB2- Low vs ERBB2- Null Advanced Gastric Cancer

    JAMA Network Open, 2026

    DOI 10.1001/jamanetworkopen.2026.24180 PMID 42479431 Frei zugänglicher VolltextQuelle: OpenAlex

  2. Aspirin use and outcomes with immune checkpoint inhibitors in metastatic cancer.

    Journal of Clinical Oncology, 2026

    DOI 10.1200/jco.2026.44.16_suppl.e14584 1 Zitation (OpenAlex) Quelle: OpenAlex

  3. Concordance Between ChatGPT and Real-World Adjuvant Chemotherapy Decisions in pT3N0 Colon Cancer

    Eurasian Journal of Medical Investigation, 2026

    DOI 10.14744/ejmi.2612508 Quelle: ORCID

  4. Reevaluating regorafenib: Do we need the full dose?

    Turkish Journal of Clinics and Laboratory, 2026

    DOI 10.18663/tjcl.1874059 Frei zugänglicher VolltextQuelle: ORCID

  5. Decoding Immunotherapy Response in Colorectal Cancer: Translational Insights Beyond MSI

    Cancers, 2026

    DOI 10.3390/cancers18050852 PMID 41827785 9 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  6. Immunotherapy expectations and knowledge in practice and clinical trials: a cross-sectional study

    Figshare, 2026

    DOI 10.6084/m9.figshare.31064068 Frei zugänglicher VolltextQuelle: OpenAlex

  7. Midday immune checkpoint inhibitor (ICI) infusion influence on survival in patients with metastatic cancer: A real-world chrono-immunotherapy study.

    Journal of Clinical Oncology, 2026

    DOI 10.1200/jco.2026.44.16_suppl.11162 Frei zugänglicher VolltextQuelle: OpenAlex

  8. 510P Clinical and molecular characterization of HER2-low gastroesophageal adenocarcinoma: Multicenter cohort data

    Annals of Oncology, 2026

    DOI 10.1016/j.annonc.2026.05.550 Frei zugänglicher VolltextQuelle: OpenAlex

  9. Efficacy of anti-VEGF & anti-EGFRs in microsatellite instable (MSI-H) metastatic colorectal cancer, Turkish Oncology Group (TOG) study.

    Journal of Clinical Oncology, 2025

    DOI 10.1200/jco.2025.43.16_suppl.e15507 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  10. Efficacy of Anti-VEGF and Anti-EGFRs in Microsatellite Instable (MSI-H) Metastatic Colorectal Cancer in a Turkish Oncology Group (TOG) Cohort Study

    Current Oncology, 2025

    DOI 10.3390/curroncol32110639 PMID 41294701 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  11. Impact of comorbidity on survival in cancer patients receiving immune checkpoint inhibitors

    Clinical and Translational Oncology, 2025

    DOI 10.1007/s12094-025-03848-7 PMID 39873944 4 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  12. Comments on "Folic acid deficiency as a modifiable risk factor for anastomotic leak in patients undergoing colorectal cancer surgery"

    Updates in surgery, 2025

    DOI 10.1007/s13304-025-02336-5 PMID 40691394 Frei zugänglicher VolltextQuelle: Europe PMC

  13. Immunotherapy expectations and knowledge in practice and clinical trials: a cross-sectional study

    Immunotherapy, 2025

    DOI 10.1080/1750743x.2026.2616477 PMID 41530958 Frei zugänglicher VolltextQuelle: ORCID

  14. Individualized Triplet Chemotherapy Decision-Making in Metastatic Colorectal Cancer: A Machine-Learning-Driven Study

    Cancers, 2025

    DOI 10.3390/cancers17223704 PMID 41301066 Frei zugänglicher VolltextQuelle: ORCID

  15. Exploring the metabolic-immune score in advanced NSCLC treated with immunotherapy

    Scientific Reports, 2025

    DOI 10.1038/s41598-025-16788-7 PMID 40841737 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  16. Neoadjuvan Rektal Skorun (NAR) Mide Kanserinde Kullanımı

    Akademik Gastroenteroloji Dergisi, 2025

    DOI 10.17941/agd.1705650 Frei zugänglicher VolltextQuelle: ORCID

  17. Combined preoperative and post-adjuvant-chemotherapy carcinoembryonic antigen levels are prognostic for early recurrence and survival in stage III colon cancer

    The American Journal of Surgery, 2025

    DOI 10.1016/j.amjsurg.2025.116256 PMID 40015199 Quelle: ORCID

  18. Stage‐specific characterization of “early‐onset colorectal cancer”: Localized and synchronous metastatic disease

    International Journal of Cancer, 2025

    DOI 10.1002/ijc.35336 PMID 39887374 7 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  19. Lymph Node Ratio (LNR) Discriminates Prognostication in pN1a-b and pN2 Stage-III Colon Cancer

    Journal of Cancer, 2025

    DOI 10.7150/jca.104336 PMID 39895795 5 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  20. Opioid knowledge and concerns: Challenges among physicians in Turkey.

    Journal of Clinical Oncology, 2025

    DOI 10.1200/jco.2025.43.16_suppl.e13541 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  21. Lactate Dehydrogenase in Patients with Metastatic Colorectal Cancer: Retrospective Study to Explore a Target Subgroup for Utilization as a Tumor Marker

    Turkish Journal of Colorectal Disease, 2025

    DOI 10.4274/tjcd.galenos.2025.2025-6-11 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  22. 899eP Individualised triplet chemotherapy decision-making in metastatic colorectal cancer: A machine learning–driven study

    Annals of Oncology, 2025

    DOI 10.1016/j.annonc.2025.08.1469 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  23. Impact of SARS-CoV-2 mRNA-BNT162b2 vaccination on survival outcomes in metastatic colorectal cancer patients treated with bevacizumab-based therapy.

    Journal of Clinical Oncology, 2025

    DOI 10.1200/jco.2025.43.16_suppl.3574 Frei zugänglicher VolltextQuelle: OpenAlex

  24. 429P Prognostic significance of HER2-low status in advanced gastric cancer

    Annals of Oncology, 2025

    DOI 10.1016/j.annonc.2025.05.445 Frei zugänglicher VolltextQuelle: OpenAlex

  25. HALP Score as a Predictor of Neoadjuvant Chemotherapy Response in Gastric and Gastroesophageal Junction Adenocarcinoma

    Journal of Oncological Sciences, 2025

    DOI 10.37047/jos.galenos.2025.2025-3-20 Frei zugänglicher VolltextQuelle: OpenAlex

  26. Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: a retrospective multi-center study by the Turkish Oncology Group (TOG)

    European Archives of Oto-Rhino-Laryngology, 2024

    DOI 10.1007/s00405-024-08744-4 PMID 38795147 5 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  27. Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: A retrospective multi-center study by the Turkish Oncology Group (TOG).

    Journal of Clinical Oncology, 2024

    DOI 10.1200/jco.2024.42.16_suppl.e18004 Quelle: ORCID

  28. Comparison of FOLFOX/CAPOX and Sorafenib in Locally Advanced or Metastatic Hepatocellular Carcinoma

    Journal of Ankara University Faculty of Medicine, 2024

    DOI 10.4274/atfm.galenos.2024.81557 Frei zugänglicher VolltextQuelle: OpenAlex

  29. Treatment approaches and survival outcomes in elderly colorectal cancer patients: a single-center comparative study

    Clinical and Translational Oncology, 2024

    DOI 10.1007/s12094-024-03758-0 PMID 39467964 4 Zitationen (Europe PMC) Quelle: ORCID

  30. Impact of low sodium values on survival outcomes of patients with cancer receiving immune checkpoint inhibitors

    Immunotherapy, 2024

    DOI 10.1080/1750743x.2024.2370231 PMID 39016058 3 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  31. Types and Rates of COVID-19 Vaccination in Patients With Newly Diagnosed Microsatellite Stable and Instable Non-Metastatic Colon Cancer

    Cureus, 2024

    DOI 10.7759/cureus.61780 PMID 38975417 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  32. Advancements in the Management of Synchronous Colorectal Liver Metastases: A Comprehensive Review of Surgical, Systemic, and Local Treatment Modalities

    Current Oncology Reports, 2024

    DOI 10.1007/s11912-024-01548-z PMID 38776011 12 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  33. Unveiling the Role of Human Papillomavirus in Urogenital Carcinogenesis a Comprehensive Review

    Viruses, 2024

    DOI 10.3390/v16050667 PMID 38793549 8 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  34. Exploring the Connection Between Microsatellite Instability and Inflammatory Indicators in Cancers

    Future Oncology, 2024

    DOI 10.2217/fon-2023-0695 PMID 38318682 1 Zitation (Europe PMC) Quelle: ORCID

  35. Adjuvant Chemotherapy Duration and Disease-Free Survival in Low-Risk Stage III Colon Cancer with N1a-b and N1c Disease: Insights from a Single-Center Retrospective Analysis

    Journal of Gastrointestinal Cancer, 2024

    DOI 10.1007/s12029-024-01135-2 PMID 39480587 4 Zitationen (OpenAlex) Quelle: OpenAlex

  36. Goblet Cell Adenocarcinoma of the Appendix: A Case Report and Review of the Literature

    Turkish Journal of Colorectal Disease, 2024

    DOI 10.4274/tjcd.galenos.2024.2024-4-5 Frei zugänglicher VolltextQuelle: OpenAlex

  37. 21P The impact of adjuvant chemotherapy duration on progression-free survival in low-risk stage III colon cancer with N1a-b and N1c disease: A retrospective, single-center analysis

    Annals of Oncology, 2024

    DOI 10.1016/j.annonc.2024.05.032 Frei zugänglicher VolltextQuelle: OpenAlex

  38. Relationship Between ABO Blood Group and Microsatellite Instability in Colorectal Cancer: A Retrospective Single-Center Study

    Journal of Gastrointestinal Cancer, 2023

    DOI 10.1007/s12029-023-00958-9 PMID 37414939 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  39. Determining Subclinical Cardiovascular and Cardiac Diseases in Patients with Non-Alcoholic Fatty Liver Disease

    The Turkish Journal of Gastroenterology, 2023

    DOI 10.5152/tjg.2022.22075 PMID 36445056 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID